Pages that link to "Q37074620"

The following pages link to Biology and treatment of acute lymphoblastic leukemia (Q37074620):

Displaying 40 items.

• Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer (Q24193790) (← links)
• Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer (Q24234833) (← links)
• Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer (Q24241602) (← links)
• Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia (Q24597084) (← links)
• A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study (Q24651897) (← links)
• Exploring sleep-wake experiences of mothers during maintenance therapy for their child's acute lymphoblastic leukemia (Q33894109) (← links)
• Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia (Q33934165) (← links)
• miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias (Q33957558) (← links)
• Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia (Q34095678) (← links)
• L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase (Q34400424) (← links)
• Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia (Q35075158) (← links)
• Anxiety, depression, stress, and cortisol levels in mothers of children undergoing maintenance therapy for childhood acute lymphoblastic leukemia (Q35158701) (← links)
• Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration (Q36043664) (← links)
• Epidemiological, clinical, cytologic and immunophenotypic aspects of acute leukemia in children: the experience at the hematology laboratory of IBN SINA University Hospital Center (Q37131265) (← links)
• Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia (Q37187510) (← links)
• Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia (Q37327945) (← links)
• L-Asparaginase Isolated from Phaseolus vulgaris Seeds Exhibited Potent Anti-Acute Lymphoblastic Leukemia Effects In-Vitro and Low Immunogenic Properties In-Vivo. (Q37379199) (← links)
• MicroRNAs in acute leukemia: from biological players to clinical contributors (Q37893954) (← links)
• Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia (Q37901917) (← links)
• L-asparaginase: an effective agent in the treatment of acute lymphoblastic leukemia (Q38105626) (← links)
• RasGRP Ras guanine nucleotide exchange factors in cancer (Q38205441) (← links)
• Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia. (Q38248280) (← links)
• VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis (Q41581040) (← links)
• NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols (Q42878950) (← links)
• Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics (Q43465426) (← links)
• Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40. (Q44232638) (← links)
• Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition (Q44329919) (← links)
• Development of figurative language skills following central nervous system-directed chemotherapy delivered in early childhood. (Q45397814) (← links)
• Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group (Q45873829) (← links)
• Neurocognitive Consequences of Childhood Leukemia and Its Treatment. (Q48109696) (← links)
• Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia. (Q48161555) (← links)
• Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype (Q51917960) (← links)
• MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2. (Q52852668) (← links)
• Different outcome in older children with acute lymphoblastic leukemia with different treatment protocols in the Netherlands (Q52899018) (← links)
• Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice. (Q53014072) (← links)
• Effect of allogeneic blood transfusion on levels of IL-6 and sIL-R2 in peripheral blood of children with acute lymphocytic leukemia. (Q55512837) (← links)
• Case report of long-term survival with metastatic triple-negative breast carcinoma: Treatment possibilities for metastatic disease (Q64238598) (← links)
• Psychiatric Aspects of Pediatric Cancer (Q84797932) (← links)
• Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years) (Q90372391) (← links)
• HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway (Q92022584) (← links)